is the fda stopping compounded tirzepatide ban on tirzepatide: Switch to name brand medications Compounded Tirzepatide With B6 (Pyridoxine)

Not bad exposure for the work were doing to enable life sciences product manufacturing here at home

Over 18 months, ischaemic optic neuropathy occurred in roughly 8.5 per 10,000 GLP-1 users, compared with about 5.5 per 10,000 among those taking SGLT2 inhibitors

Independent Pharmacy and Specialty Pharmacy Operators For private equity and strategic investors in independent pharmacy or specialty pharmacy, the regulatory environment in 2025-2026 is more favorable than at any point in the past 15 years, given the momentum behind structural PBM reform

I had a big butt

With demand rising worldwide, the opportunity to supply safe, affordable GLP-1 generics is larger than ever